Trial Profile
Phase 1 Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Toxic shock syndrome toxin-1 variant vaccine (Primary)
- Indications Septic shock
- Focus Adverse reactions; First in man
- Sponsors Biomedizinische Forschungs
- 08 Jul 2017 New trial record